Phio Pharmaceuticals
$1.0200
56
-$0.02-1.92% Friday 20:00
-$0.01-0.98%Friday 23:22After hours
Statistics
Day High
1.03
Day Low
1.025
52W High
4.19
52W Low
0.813
Volume
1,797
Avg. Volume
-
Mkt Cap
11.85M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
6AugExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-4.59
-3.14
-1.69
-0.24
Expected EPS
-0.36
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-8.7MNet Income
Analyst Ratings
14.00Average Price Target
The highest estimate is 14.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PHIO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap31.65B
Alnylam Pharmaceuticals
ALNY
Mkt Cap41.76B
Arrowhead Pharmaceuticals
ARWR
Mkt Cap11.83B
Ionis Pharmaceuticals
IONS
Mkt Cap13.52B
Sarepta Therapeutics
SRPT
Mkt Cap2.04B
Biomarin Pharmaceutical
BMRN
Mkt Cap11.4B
CRISPR Therapeutics
CRSP
Mkt Cap5.92B
Intellia Therapeutics
NTLA
Mkt Cap2.45B
About
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.
Show more...
CEO
Mr. Robert J. Bitterman
Employees
6
Country
United States
ISIN
US71880W5013
Listings
0 Comments
Share your thoughts
FAQ
What is Phio Pharmaceuticals stock price today?▼
The current price of PHIO is $1.02 USD — it has decreased by -1.92% in the past 24 hours. Watch Phio Pharmaceuticals stock price performance more closely on the chart.
What is Phio Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Phio Pharmaceuticals stocks are traded under the ticker PHIO.
Is Phio Pharmaceuticals stock price growing?▼
PHIO stock has risen by +2% compared to the previous week, the month change is a -4.67% fall, over the last year Phio Pharmaceuticals has showed a -55.84% decrease.
What is Phio Pharmaceuticals market cap?▼
Today Phio Pharmaceuticals has the market capitalization of 11.85M
When is the next Phio Pharmaceuticals earnings date?▼
Phio Pharmaceuticals is going to release the next earnings report on August 06, 2026.
What were Phio Pharmaceuticals earnings last quarter?▼
PHIO earnings for the last quarter are -0.34 USD per share, whereas the estimation was -0.24 USD resulting in a -44.68% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Phio Pharmaceuticals revenue for the last year?▼
Phio Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Phio Pharmaceuticals net income for the last year?▼
PHIO net income for the last year is -8.7M USD.
How many employees does Phio Pharmaceuticals have?▼
As of July 12, 2026, the company has 6 employees.
In which sector is Phio Pharmaceuticals located?▼
Phio Pharmaceuticals operates in the Health & Wellness sector.
When did Phio Pharmaceuticals complete a stock split?▼
The last stock split for Phio Pharmaceuticals was on July 05, 2024 with a ratio of 1:9.
Where is Phio Pharmaceuticals headquartered?▼
Phio Pharmaceuticals is headquartered in King of Prussia, United States.